Please assess the completion status of the following clinical trial:

Trial Title: Smoking Termination Enhancement Project (STEP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Aged between 18 and 65 years old~2. Capable of providing informed consent, attend all study visits and comply with the protocol~3. Daily smoker for at least one year and currently smoke an average of at least 10 cigarettes per day~4. Report a motivation to quit smoking in the next month of at least 5 on a 10-point scale~5. Score of 20 or greater on 16-item Anxiety Sensitivity Index~6. Physically inactive as defined as participating in moderate-intensity exercise less than 2 days/week (duration must be 30 minutes or less each time)~Exclusion Criteria:~1. Use of other tobacco products~2. General medical condition(s) that contraindicate exercise~3. Resting blood pressure of ≥ 160 systolic and/or 100 diastolic who are not receiving treatment for high blood pressure~4. Blood lipid levels ≥ 240 mg/dl with LDL-C ≥ 160 mg/dl or triglyceride levels ≥ 300 mg/dl (individuals receiving medical treatment for lipid abnormalities with lipid levels above the cut-offs will be eligible with physician written approval)~5. Body mass index ≥40~6. Currently suicidal or high suicide risk~7. Current or past psychotic disorders of any type, or comorbid psychiatric conditions that are relative or absolute contraindications to the use of any treatment option in the study protocol~8. Currently pregnant, planning on becoming pregnant in the next year, or current breastfeeding~9. Alcohol or drug dependence; abuse of depressants, dissociative anesthetics, hallucinogens, opioids, or cocaine within the last 6 months~10. Psychotherapy initiated within the past three months, or ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety or mood disorder other than general supportive therapy~11. Current use of any psychotherapy or pharmacotherapy for smoking cessation not provided by the researchers, including Chantix, Zyban, Welbutrin and Nortriptyline.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Standard Care plus Wellness Program (Type: ACTIVE_COMPARATOR): None
- Standard Care plus Exercise Program (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).